Diferencia entre revisiones de «Labetalol»
(Text replacement - "α1 blocker" to "α<sub>1</sub>-blocker") |
|||
| Línea 17: | Línea 17: | ||
*Renal Dosing | *Renal Dosing | ||
**Adult | **Adult | ||
*** No renal dosing adjustments necessary. Drug not removed with hemodialysis | |||
**Pediatric | **Pediatric | ||
*** No renal dosing adjustments necessary. Drug not removed with hemodialysis | |||
*Hepatic Dosing | *Hepatic Dosing | ||
**Adult | **Adult | ||
*** May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution. | |||
**Pediatric | **Pediatric | ||
*** May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution. | |||
==Indications== | ==Indications== | ||
Revisión del 17:21 2 abr 2019
General
- Type: Beta blockers
- Dosage Forms:
- Common Trade Names:
Adult Dosing
- Bolus dosing
- 20mg IV followed by 40-80mg q10min up to total of 300mg
- Infusion dosing
- 0.5-2mg/min
Pediatric Dosing
Special Populations
- Pregnancy Rating: C
- Lactation: Compatible with breastfeeding
- Renal Dosing
- Adult
- No renal dosing adjustments necessary. Drug not removed with hemodialysis
- Pediatric
- No renal dosing adjustments necessary. Drug not removed with hemodialysis
- Adult
- Hepatic Dosing
- Adult
- May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
- Pediatric
- May need reduced dosing given decreased metabolism and increased oral bioavailability with hepatic impairment however no specific dosing adjustments in manufacturer labeling. Use caution.
- Adult
Indications
- hypertension in setting of myocardial ischemia
- hypertension in setting of neurologic injury
- hypertension in setting of preeclampsia/eclampsia
Contraindications
- Allergy to class/drug
Adverse Reactions
- Orthostatic hypotension
Pharmacology
- Half-life: 5-8hrs
- Metabolism: Hepatic via conjugation
- Excretion: Renal 55-60%
- Mechanism of Action:
- Class II - Nonselective β-blocker
- α1-blocker
- Onset of action = 2-5min (IV)
- Duration of action = 2-4hr (IV)
